☰

Qianni Cheng, Ph.D. - Publications

Affiliations: 
2010 The Chinese University of Hong Kong, Hong Kong, Hong Kong 
Area:
1. Drug resistant of pathogenic bacteria. 2. Molecular virology of HIV and HBV.
Tree Info Grants Similar researchers PubMed Report error

6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Zhang D, So WY, Wang Y, Wu SY, Cheng Q, Leung PS. Insulinotropic effects of GPR120 agonists are altered in obese non-diabetic and diabetic states. Clinical Science (London, England : 1979). PMID 27980130 DOI: 10.1042/Cs20160545  0.306
2015 So WY, Cheng Q, Xu A, Lam KS, Leung PS. Loss of fibroblast growth factor 21 action induces insulin resistance, pancreatic islet hyperplasia and dysfunction in mice. Cell Death & Disease. 6: e1707. PMID 25811804 DOI: 10.1038/Cddis.2015.80  0.315
2015 Chen L, So WY, Li SY, Cheng Q, Boucher BJ, Leung PS. Niacin-induced hyperglycemia is partially mediated via niacin receptor GPR109a in pancreatic islets. Molecular and Cellular Endocrinology. 404: 56-66. PMID 25622782 DOI: 10.1016/J.Mce.2015.01.029  0.324
2013 So WY, Cheng Q, Chen L, Evans-Molina C, Xu A, Lam KS, Leung PS. High glucose represses β-klotho expression and impairs fibroblast growth factor 21 action in mouse pancreatic islets: involvement of peroxisome proliferator-activated receptor γ signaling. Diabetes. 62: 3751-9. PMID 23897951 DOI: 10.2337/Db13-0645  0.32
2010 Leung PS, Cheng Q. The novel roles of glucagon-like peptide-1, angiotensin II, and vitamin D in islet function. Advances in Experimental Medicine and Biology. 654: 339-61. PMID 20217505 DOI: 10.1007/978-90-481-3271-3_15  0.323
2008 Cheng Q, Law PK, de Gasparo M, Leung PS. Combination of the dipeptidyl peptidase IV inhibitor LAF237 [(S)-1-[(3-hydroxy-1-adamantyl)ammo]acetyl-2-cyanopyrrolidine] with the angiotensin II type 1 receptor antagonist valsartan [N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl]-L-valine] enhances pancreatic islet morphology and function in a mouse model of type 2 diabetes. The Journal of Pharmacology and Experimental Therapeutics. 327: 683-91. PMID 18787107 DOI: 10.1124/Jpet.108.142703  0.322
Show low-probability matches.